A systematic review: Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma

Journal of the American College of Surgeons

Volumn 215, Issue 6, 2012, Pages 820-830

  Mavros, Michael N ^a,b   Mayo, Skye C ^a   Hyder, Omar ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ABLATION THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COMORBIDITY; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 84869505053     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.08.001     Document Type: Article

References (62)

1. H.A. Edmondson Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood AMA J Dis Child 91 1956 168 186
2. S.C. Ward, and S. Waxman Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors Semin Liver Dis 31 2011 61 70
3. S. Liu, K.W. Chan, B. Wang, and L. Qiao Fibrolamellar hepatocellular carcinoma Am J Gastroenterol 104 2009 2617 2624 quiz 2625
4. M. Torbenson Review of the clinicopathologic features of fibrolamellar carcinoma Adv Anat Pathol 14 2007 217 223
5. H.B. El-Serag, and J.A. Davila Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study Hepatology 39 2004 798 803
6. J.R. Craig, R.L. Peters, H.A. Edmondson, and M. Omata Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features Cancer 46 1980 372 379
7. A.W. Hemming, B. Langer, and P. Sheiner Aggressive surgical management of fibrolamellar hepatocellular carcinoma J Gastrointest Surg 1 1997 342 346
8. G. El-Gazzaz, W. Wong, and M.K. El-Hadary Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma Transpl Int 13 Suppl 1 2000 S406 S409
9. T. Kanai, T. Takabayashi, and Y. Kawano A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female Jpn J Clin Oncol 34 2004 346 351
10. F.J. Paradinas, W.M. Melia, and M.L. Wilkinson High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma Br Med J (Clin Res Ed) 285 1982 840 842
11. K.J. Sheppard, D.A. Bradbury, J.M. Davies, and D.R. Ryrie High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma Br Med J (Clin Res Ed) 286 1983 57
12. S. van Tonder, M.C. Kew, and J. Hodkinson Serum vitamin B12 binders in South African blacks with hepatocellular carcinoma Cancer 56 1985 789 792
13. K. Wheeler, J. Pritchard, W. Luck, and M. Rossiter Transcobalamin I as a "marker" for fibrolamellar hepatoma Med Pediatr Oncol 14 1986 227 229
14. J.A. Ehrenfried, Z. Zhou, J.C. Thompson, and B.M. Evers Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma Ann Surg 220 1994 484 489 discussion 489-491
15. O. Soreide, A. Czerniak, and H. Bradpiece Characteristics of fibrolamellar hepatocellular carcinoma A study of nine cases and a review of the literature Am J Surg 151 1986 518 523
16. N.A. Collier, K. Weinbren, and S.R. Bloom Neurotensin secretion by fibrolamellar carcinoma of the liver Lancet 1 1984 538 540
17. S. Dhingra, W. Li, and D. Tan Cell cycle biology of fibrolamellar hepatocellular carcinoma Int J Clin Exp Pathol 3 2010 792 797
18. J.Y. Scoazec, J.F. Flejou, and A. D'Errico Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules Hepatology 24 1996 1128 1136
19. T. Ichikawa, M.P. Federle, and L. Grazioli Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases Radiology 213 1999 352 361
20. J.K. McLarney, P.T. Rucker, and G.N. Bender Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation Radiographics 19 1999 453 471
21. A.C. Friedman, J.E. Lichtenstein, and Z. Goodman Fibrolamellar hepatocellular carcinoma Radiology 157 1985 583 587
22. SciVerse Scopus Scopus in detail http://www.info.sciverse.com/scopus/ scopus-in-detail/facts Accessed May 21, 2012
23. M.E. Falagas, E.I. Pitsouni, G.A. Malietzis, and G. Pappas Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses FASEB J 22 2008 338 342
24. E.S. Rosmarakis, E.S. Soteriades, and P.I. Vergidis From conference abstract to full paper: differences between data presented in conferences and journals FASEB J 19 2005 673 680
25. M.A. Berman, J.A. Burnham, and D.G. Sheahan Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature Hum Pathol 19 1988 784 794
26. F. Bhaijee, J.E. Krige, M.L. Locketz, and M.C. Kew Liver resection for non-cirrhotic hepatocellular carcinoma in South African patients S Afr J Surg 49 2011 68 74
27. F. Bhaijee, M.L. Locketz, and J.E. Krige Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series S Afr J Surg 47 2009 108 111
28. B.E. Epstein, T.F. Pajak, and T.L. Haulk Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history Am J Clin Oncol 22 1999 22 28
29. D.C. Farhi, R.H. Shikes, P.J. Murari, and S.G. Silverberg Hepatocellular carcinoma in young people Cancer 52 1983 1516 1525
30. J.E. Haas, K.A. Muczynski, and M. Krailo Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma Cancer 64 1989 1082 1095
31. T. Ichikawa, M.P. Federle, L. Grazioli, and W. Marsh Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging Radiology 217 2000 145 151
32. D.C. Ihde, M.J. Matthews, and R.W. Makuch Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy Identification of two groups of patients with prospects for prolonged survival Am J Med 78 1985 399 406
33. S. Iwatsuki, T.E. Starzl, and D.G. Sheahan Hepatic resection vs transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 228 discussion 228-229
34. S. Kakar, L.J. Burgart, and K.P. Batts Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis Mod Pathol 18 2005 1417 1423
35. H.M. Katzenstein, M.D. Krailo, and M.H. Malogolowkin Fibrolamellar hepatocellular carcinoma in children and adolescents Cancer 97 2003 2006 2012
36. G.B. Klintmalm Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome Ann Surg 228 1998 479 490
37. V. Maniaci, B.R. Davidson, and K. Rolles Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy Eur J Surg Oncol 35 2009 617 621
38. A. Marcos-Alvarez, R.L. Jenkins, and W.K. Washburn Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center Arch Surg 131 1996 292 298
39. A. Martinez Isla, A. Ferrara, and J.M. Badia Fibrolamellar hepatocellular carcinoma: results of partial liver resection Rev Esp Enferm Dig 89 1997 699 705
40. J.R. McPeake, J.G. O'Grady, and S. Zaman Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome J Hepatol 18 1993 226 234
41. L.E. Moreno-Luna, O. Arrieta, and J. Garcia-Leiva Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma BMC Cancer 5 2005 142
42. D.M. Nagorney, M.A. Adson, and L.H. Weiland Fibrolamellar hepatoma Am J Surg 149 1985 113 119
43. K.M. Ng, T.D. Yan, and D. Black Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma HPB (Oxford) 11 2009 311 320
44. J.G. O'Grady, R.J. Polson, and K. Rolles Liver transplantation for malignant disease Results in 93 consecutive patients Ann Surg 207 1988 373 379
45. Y.Z. Patt, M.M. Hassan, and R.D. Lozano Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma J Clin Oncol 21 2003 421 427
46. I. Penn Hepatic transplantation for primary and metastatic cancers of the liver Surgery 110 1991 726 734 discussion 734-735
47. R. Pichlmayr, A. Weimann, and K.J. Oldhafer Role of liver transplantation in the treatment of unresectable liver cancer World J Surg 19 1995 807 813
48. R. Pichlmayr, A. Weimann, G. Tusch, and H.J. Schlitt Indications and role of liver transplantation for malignant tumors Oncologist 2 1997 164 170
49. A.D. Pinna, S. Iwatsuki, and R.G. Lee Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation Hepatology 26 1997 877 883
50. B. Ringe, C. Wittekind, and A. Weimann Results of hepatic resection and transplantation for fibrolamellar carcinoma Surg Gynecol Obstet 175 1992 299 305
51. T.E. Starzl, S. Iwatsuki, and B.W. Shaw Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver Surg Gynecol Obstet 162 1986 145 148
52. W.R. Stevens, C.D. Johnson, D.H. Stephens, and D.M. Nagorney Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management AJR Am J Roentgenol 164 1995 1153 1158
53. F. Stipa, S.S. Yoon, and K.H. Liau Outcome of patients with fibrolamellar hepatocellular carcinoma Cancer 106 2006 1331 1338
54. J.N. Vauthey, D. Klimstra, and D. Franceschi Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma Am J Surg 169 1995 28 34 discussion 34-35
55. Y. Wang, J. Zhang, and Y. Gao Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes Chin Med J (Engl) 112 1999 264 268
56. W.J. Wood, M. Rawlings, H. Evans, and C.N. Lim Hepatocellular carcinoma: importance of histologic classification as a prognostic factor Am J Surg 155 1988 663 666
57. I. Yokoyama, S. Todo, S. Iwatsuki, and T.E. Starzl Liver transplantation in the treatment of primary liver cancer Hepatogastroenterology 37 1990 188 193
58. M.E. Falagas, V.D. Kouranos, and A. Michalopoulos Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences Clin Infect Dis 50 2010 468 472
59. D.G. Altman Statistics and ethics in medical research: III How large a sample? Br Med J 281 1980 1336 1338
60. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
61. R. Adam, P. McMaster, and J.G. O'Grady Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry Liver Transpl 9 2003 1231 1243
62. R.W. Busuttil, and D.G. Farmer The surgical treatment of primary hepatobiliary malignancy Liver Transpl Surg 2 1996 114 130